| Application no. and date | 17857471.1 (espacenet) (Federated) (European Patent Register), 20170929 | | Patent/reg. no. and date | DK/EP 3519049, 20251203 | | Publication date | 20190807 | | Priority no. and date | US 201662402403 P, 20160930, US 201762532068 P, 20170713 | | EP pub. no. and date |
EP 3519049 20190807 | | Effective date | | | Applicant/owner | Janssen Biotech, Inc., 800/850 Ridgeview Drive
Horsham, PA 19044, US | | Applicant ref. no. | BB381386EPDK | | Inventor | RANDAZZO, Bruce, 1400 McKean Road
Spring House
Pennsylvania 19477, US,
WASFI, Yasmine, 1400 McKean Road
Spring House
Pennsylvania 19477, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61P 25/00 (2006.01) , A61P 37/00 (2006.01) , C07K 16/24 (2006.01) | | Title | SIKKER OG EFFEKTIV FREMGANGSMÅDE TIL BEHANDLING AF PSORIASIS MED SPECIFIKT ANTI-IL23-ANTISTOF | | Int. application no. | US2017054217 | | Int. publication no. | WO2018064436 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
